{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:14:55Z","timestamp":1780647295749,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1038\/s41440-024-02087-7","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T12:49:29Z","timestamp":1737031769000},"page":"1575-1585","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Untreated and uncontrolled hypertension in Japanese patients with spontaneous intracerebral hemorrhage"],"prefix":"10.1038","volume":"48","author":[{"given":"Tadashi","family":"Ozawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Kameda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kobari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Tetsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiro","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Ohtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Miyawaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutsumi","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuomi","family":"Kario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"2087_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1161\/STROKEAHA.108.523209","volume":"40","author":"S Sacco","year":"2009","unstructured":"Sacco S, Marini C, Toni D, Olivieri L, Carolei A. Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry. Stroke. 2009;40:394\u20139.","journal-title":"Stroke"},{"key":"2087_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(09)70340-0","volume":"9","author":"CJ van Asch","year":"2010","unstructured":"van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9:167\u201376.","journal-title":"Lancet Neurol"},{"key":"2087_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1253\/circj.CJ-13-0811","volume":"78","author":"S Gotoh","year":"2014","unstructured":"Gotoh S, Hata J, Ninomiya T, Hirakawa Y, Nagata M, Mukai N, et al. Trends in the incidence and survival of intracerebral hemorrhage by its location in a Japanese community. Circ J. 2014;78:403\u20139.","journal-title":"Circ J"},{"key":"2087_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1001\/jamaneurol.2021.4346","volume":"79","author":"K Toyoda","year":"2022","unstructured":"Toyoda K, Yoshimura S, Nakai M, Koga M, Sasahara Y, Sonoda K, et al. Twenty-Year Change in Severity and Outcome of Ischemic and Hemorrhagic Strokes. JAMA Neurol. 2022;79:61\u20139.","journal-title":"JAMA Neurol"},{"key":"2087_CR5","doi-asserted-by":"publisher","first-page":"e641","DOI":"10.1016\/S2214-109X(18)30217-1","volume":"6","author":"B Lacey","year":"2018","unstructured":"Lacey B, Lewington S, Clarke R, Kong XL, Chen Y, Guo Y, et al. Age-specific association between blood pressure and vascular and non-vascular chronic diseases in 0\u00b75 million adults in China: a prospective cohort study. Lancet Glob Health. 2018;6:e641\u2013e9.","journal-title":"Lancet Glob Health"},{"key":"2087_CR6","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/s41440-020-0508-z","volume":"43","author":"T Hisamatsu","year":"2020","unstructured":"Hisamatsu T, Segawa H, Kadota A, Ohkubo T, Arima H, Miura K. Epidemiology of hypertension in Japan: beyond the new 2019 Japanese guidelines. Hypertens Res. 2020;43:1344\u201351.","journal-title":"Hypertens Res"},{"key":"2087_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1600-0404.2009.01197.x","volume":"121","author":"TC Turin","year":"2010","unstructured":"Turin TC, Rumana N, Kita Y, Nakamura Y, Ueshima H. Untreated or uncontrolled cardiovascular risk factors are associated with an increased risk of cerebral hemorrhage during colder periods. Acta Neurol Scand. 2010;121:67\u20139.","journal-title":"Acta Neurol Scand"},{"key":"2087_CR8","doi-asserted-by":"publisher","first-page":"e2121921","DOI":"10.1001\/jamanetworkopen.2021.21921","volume":"4","author":"SJ Kittner","year":"2021","unstructured":"Kittner SJ, Sekar P, Comeau ME, Anderson CD, Parikh GY, Tavarez T, et al. Ethnic and Racial Variation in Intracerebral Hemorrhage Risk Factors and Risk Factor Burden. JAMA Netw Open. 2021;4:e2121921.","journal-title":"JAMA Netw Open"},{"key":"2087_CR9","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1136\/jnnp-2020-325648","volume":"92","author":"M Locatelli","year":"2021","unstructured":"Locatelli M, Grassi M, Saba V, Iacovello L, di Castelnuovo A, de Gaetano G, et al. Age-dependent effect of susceptibility factors on the risk of intracerebral haemorrhage: Multicenter Study on Cerebral Hemorrhage in Italy (MUCH-Italy). J Neurol Neurosurg Psychiatry. 2021;92:1068\u201371.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2087_CR10","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1161\/CIRCULATIONAHA.116.024073","volume":"134","author":"KB Walsh","year":"2016","unstructured":"Walsh KB, Woo D, Sekar P, Osborne J, Moomaw CJ, Langefeld CD, et al. Untreated Hypertension: A Powerful Risk Factor for Lobar and Nonlobar Intracerebral Hemorrhage in Whites, Blacks, and Hispanics. Circulation. 2016;134:1444\u201352.","journal-title":"Circulation"},{"key":"2087_CR11","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/jnnp-2015-312736","volume":"87","author":"A Pezzini","year":"2016","unstructured":"Pezzini A, Grassi M, Iacoviello L, Zedde M, Marcheselli S, Silvestrelli G, et al. Serum cholesterol levels, HMG-CoA reductase inhibitors and the risk of intracerebral haemorrhage. The Multicenter Study on Cerebral Haemorrhage in Italy (MUCH-Italy). J Neurol Neurosurg Psychiatry. 2016;87:924.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2087_CR12","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019;42:1235\u2013481.","journal-title":"Hypertens Res"},{"key":"2087_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12872-015-0053-x","volume":"15","author":"S Streit","year":"2015","unstructured":"Streit S, Kaplan V, Busato A, Djalali S, Senn O, Meli DN, et al. General Practitioners\u2019 vitamin K antagonist monitoring is associated with better blood pressure control in patients with hypertension-a cross-sectional database study. BMC Cardiovasc Disord. 2015;15:47.","journal-title":"BMC Cardiovasc Disord"},{"key":"2087_CR14","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1111\/jch.13058","volume":"19","author":"YC Chia","year":"2017","unstructured":"Chia YC, Buranakitjaroen P, Chen CH, Divinagracia R, Hoshide S, Park S, et al. Current status of home blood pressure monitoring in Asia: Statement from the HOPE Asia Network. J Clin Hypertens. 2017;19:1192\u2013201.","journal-title":"J Clin Hypertens"},{"key":"2087_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27377-2","volume":"8","author":"D Zhou","year":"2018","unstructured":"Zhou D, Xi B, Zhao M, Wang L, Veeranki SP. Uncontrolled hypertension increases risk of all-cause and cardiovascular disease mortality in US adults: the NHANES III Linked Mortality Study. Sci Rep. 2018;8:9418.","journal-title":"Sci Rep"},{"key":"2087_CR16","doi-asserted-by":"publisher","first-page":"e016581","DOI":"10.1136\/bmjopen-2017-016581","volume":"7","author":"TS Han","year":"2017","unstructured":"Han TS, Wang HH, Wei L, Pan Y, Ma Y, Wang Y, et al. Impacts of undetected and inadequately treated hypertension on incident stroke in China. BMJ Open. 2017;7:e016581.","journal-title":"BMJ Open"},{"key":"2087_CR17","doi-asserted-by":"publisher","first-page":"122968","DOI":"10.1016\/j.jns.2024.122968","volume":"459","author":"FS Sarfo","year":"2024","unstructured":"Sarfo FS, Asowata OJ, Akpa OM, Akinyemi J, Wahab K, Singh A, et al. Stroke occurrence by hypertension treatment status in Ghana and Nigeria: A case-control study. J Neurol Sci. 2024;459:122968.","journal-title":"J Neurol Sci"},{"key":"2087_CR18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s40801-020-00224-5","volume":"8","author":"S Higa","year":"2021","unstructured":"Higa S, Ii Y, Nozawa K, Yamamoto Y, Ohwaki K, Asami Y. Relationship of Annual Health Checkups with the Subject\u2019s Subsequent Behavior of Cardiovascular Risk Management in a Real-World Setting in Japan: A Retrospective Cohort Study on Changes in Antihypertensive Drug Prescription and Blood Pressure from 2015 to 2017. Drugs Real World Outcomes. 2021;8:215\u201325.","journal-title":"Drugs Real World Outcomes"},{"key":"2087_CR19","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1291\/hypres.30.921","volume":"30","author":"T Tanaka","year":"2007","unstructured":"Tanaka T, Okamura T, Yamagata Z, Takebayashi T, Tamura U, Kusaka Y, et al. Awareness and treatment of hypertension and hypercholesterolemia in Japanese workers: the High-risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) study. Hypertens Res. 2007;30:921\u20138.","journal-title":"Hypertens Res"},{"key":"2087_CR20","unstructured":"Ministry of Health Labour and Welfare. Health checkups and through medical checkup. Summary Report of Comprehensive Survey of Living Condition 2019. https:\/\/www.mhlw.go.jp\/english\/database\/db-hss\/dl\/report_gaikyo_2019.pdf. Accessed 8th November 2024."},{"key":"2087_CR21","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1007\/s00415-023-11601-9","volume":"270","author":"OR Mafruhah","year":"2023","unstructured":"Mafruhah OR, Huang YM, Lin HW. Impacts of medication non-adherence to major modifiable stroke-related diseases on stroke prevention and mortality: a meta-analysis. J Neurol. 2023;270:2504\u201316.","journal-title":"J Neurol"},{"key":"2087_CR22","doi-asserted-by":"publisher","first-page":"e014435","DOI":"10.1136\/bmjopen-2016-014435","volume":"7","author":"M Feehan","year":"2017","unstructured":"Feehan M, Morrison MA, Tak C, Morisky DE, DeAngelis MM, Munger MA. Factors predicting self-reported medication low adherence in a large sample of adults in the US general population: a cross-sectional study. BMJ Open. 2017;7:e014435.","journal-title":"BMJ Open"},{"key":"2087_CR23","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1161\/HYPERTENSIONAHA.116.08729","volume":"69","author":"P Gupta","year":"2017","unstructured":"Gupta P, Patel P, \u0160trauch B, Lai FY, Akbarov A, Mare\u0161ov\u00e1 V, et al. Risk Factors for Nonadherence to Antihypertensive Treatment. Hypertension. 2017;69:1113\u201320.","journal-title":"Hypertension"},{"key":"2087_CR24","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822\u201338.","journal-title":"Lancet Neurol"},{"key":"2087_CR25","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1212\/WNL.0000000000007654","volume":"92","author":"RJ Cannistraro","year":"2019","unstructured":"Cannistraro RJ, Badi M, Eidelman BH, Dickson DW, Middlebrooks EH, Meschia JF. CNS small vessel disease: A clinical review. Neurology. 2019;92:1146\u201356.","journal-title":"Neurology"},{"key":"2087_CR26","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1212\/WNL.0b013e31829e6ffa","volume":"81","author":"LA Garc\u00eda-Rodr\u00edguez","year":"2013","unstructured":"Garc\u00eda-Rodr\u00edguez LA, Gaist D, Morton J, Cookson C, Gonz\u00e1lez-P\u00e9rez A. Antithrombotic drugs and risk of hemorrhagic stroke in the general population. Neurology. 2013;81:566\u201374.","journal-title":"Neurology"},{"key":"2087_CR27","doi-asserted-by":"publisher","first-page":"e0202575","DOI":"10.1371\/journal.pone.0202575","volume":"13","author":"S Gulati","year":"2018","unstructured":"Gulati S, Solheim O, Carlsen SM, \u00d8ie LR, Jensberg H, Gulati AM, et al. Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study. PLoS One. 2018;13:e0202575.","journal-title":"PLoS One"},{"key":"2087_CR28","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1161\/CIRCULATIONAHA.113.004876","volume":"130","author":"Y Li","year":"2014","unstructured":"Li Y, Wei FF, Thijs L, Boggia J, Asayama K, Hansen TW, et al. Ambulatory hypertension subtypes and 24-hour systolic and diastolic blood pressure as distinct outcome predictors in 8341 untreated people recruited from 12 populations. Circulation. 2014;130:466\u201374.","journal-title":"Circulation"},{"key":"2087_CR29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jcrc.2017.09.010","volume":"43","author":"M Hevesi","year":"2018","unstructured":"Hevesi M, Bershad EM, Jafari M, Mayer SA, Selim M, Suarez JI, et al. Untreated hypertension as predictor of in-hospital mortality in intracerebral hemorrhage: A multi-center study. J Crit Care. 2018;43:235\u20139.","journal-title":"J Crit Care"},{"key":"2087_CR30","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/j.1468-1331.2009.02912.x","volume":"17","author":"S Tetri","year":"2010","unstructured":"Tetri S, Huhtakangas J, Juvela S, Saloheimo P, Pyhtinen J, Hillbom M. Better than expected survival after primary intracerebral hemorrhage in patients with untreated hypertension despite high admission blood pressures. Eur J Neurol. 2010;17:708\u201314.","journal-title":"Eur J Neurol"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-02087-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-02087-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-02087-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T22:02:25Z","timestamp":1743976945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-02087-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["2087"],"URL":"https:\/\/doi.org\/10.1038\/s41440-024-02087-7","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"assertion":[{"value":"9 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"TK received lecture fees from Daiichi-Sankyo Pharmaceutical. KK received a study grants or contracts from Eisai, Daiichi-Sankyo Pharmaceutical, and E.P. medical, consulting fees from Zimmer Biomet, Ono Pharmaceutical, Viatris Pharmaceutical, and IQVIA, and lecture fees and speaker\u2019s fees from Eisai and Daiichi-Sankyo Pharmaceutical. SF received lecture fees and speaker\u2019s fees from Daiichi-Sankyo Pharmaceutical, Bayer Pharmaceutical, Bristol-Myers Squibb, Nippon Boehringer Ingelheim, and Pfizer Japan. RT received lecture fees and speaker\u2019s fees from Nippon Boehringer Ingelheim, Takeda Pharmaceutical, CSL Behring, Eisai, Kowa, Daiichi-Sankyo Pharmaceutical, Kyowa Kirin, Bayer Pharmaceutical, Bristol-Myers Squibb, Otsuka Pharmaceutical, Pfizer Japan, and AbbVie GK.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}